KCM Investment Advisors’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,533
| Closed | -$49.5K | – | 379 |
|
|
2024
Q1 | $49.5K | Sell |
10,533
-1,000
| -9% | -$3.83K | ﹤0.01% | 375 |
|
|
2023
Q4 | $56.6K | Sell |
11,533
-917
| -7% | -$4.49K | ﹤0.01% | 364 |
|
|
2023
Q3 | $67.9K | Sell |
12,450
-350
| -3% | -$2.8K | ﹤0.01% | 364 |
|
|
2023
Q2 | $119K | Hold |
12,800
| – | – | ﹤0.01% | 377 |
|
|
2023
Q1 | $105K | Sell |
12,800
-127,684
| -91% | -$1.41M | ﹤0.01% | 401 |
|
|
2022
Q4 | $1.56M | Sell |
140,484
-20,946
| -13% | -$244K | 0.07% | 173 |
|
|
2022
Q3 | $1.92M | Sell |
161,430
-6,215
| -4% | -$94.1K | 0.09% | 153 |
|
|
2022
Q2 | $2.56M | Sell |
167,645
-6,490
| -4% | -$117K | 0.11% | 137 |
|
|
2022
Q1 | $3.68M | Buy |
174,135
+16,684
| +11% | +$359K | 0.13% | 124 |
|
|
2021
Q4 | $3.72M | Buy |
157,451
+16,967
| +12% | +$363K | 0.13% | 125 |
|
|
2021
Q3 | $2.82M | Buy |
140,484
+6,575
| +5% | +$135K | 0.11% | 137 |
|
|
2021
Q2 | $2.69M | Buy |
133,909
+4,431
| +3% | +$94.8K | 0.11% | 137 |
|
|
2021
Q1 | $2.75M | Buy |
129,478
+27,308
| +27% | +$587K | 0.12% | 128 |
|
|
2020
Q4 | $2.23M | Buy |
102,170
+18,800
| +23% | +$366K | 0.11% | 133 |
|
|
2020
Q3 | $1.47M | Buy |
83,370
+25,869
| +45% | +$481K | 0.08% | 147 |
|
|
2020
Q2 | $1.08M | Buy |
57,501
+2,518
| +5% | +$44.6K | 0.06% | 170 |
|
|
2020
Q1 | $951K | Buy |
54,983
+12,818
| +30% | +$268K | 0.06% | 165 |
|
|
2019
Q4 | $890K | Buy |
42,165
+3,965
| +10% | +$80.3K | 0.05% | 191 |
|
|
2019
Q3 | $747K | Buy |
38,200
+5,326
| +16% | +$97.8K | 0.04% | 197 |
|
|
2019
Q2 | $573K | Buy |
32,874
+9,014
| +38% | +$162K | 0.03% | 222 |
|
|
2019
Q1 | $442K | Buy |
23,860
+10,731
| +82% | +$191K | 0.03% | 239 |
|
|
2018
Q4 | $211K | Buy |
13,129
+700
| +6% | +$11.1K | 0.01% | 462 |
|
|
2018
Q3 | $185K | Hold |
12,429
| – | – | 0.01% | 507 |
|
|
2018
Q2 | $175K | Sell |
12,429
-3,000
| -19% | -$39.7K | 0.01% | 515 |
|
|
2018
Q1 | $201K | Sell |
15,429
-500
| -3% | -$6.4K | 0.01% | 509 |
|
|
2017
Q4 | $220K | Sell |
15,929
-990
| -6% | -$13.4K | 0.01% | 485 |
|
|
2017
Q3 | $222K | Hold |
16,919
| – | – | 0.01% | 489 |
|
|
2017
Q2 | $218K | Hold |
16,919
| – | – | 0.01% | 505 |
|
|
2017
Q1 | $218K | Hold |
16,919
| – | – | 0.01% | 506 |
|
|
2016
Q4 | $208K | Sell |
16,919
-250
| -1% | -$3.23K | 0.01% | 510 |
|
|
2016
Q3 | $254K | Hold |
17,169
| – | – | 0.02% | 474 |
|
|
2016
Q2 | $261K | Hold |
17,169
| – | – | 0.02% | 453 |
|
|
2016
Q1 | $223K | Hold |
17,169
| – | – | 0.02% | 487 |
|
|
2015
Q4 | $198K | Sell |
17,169
-1,000
| -6% | -$11.4K | 0.02% | 494 |
|
|
2015
Q3 | $201K | Sell |
18,169
-4,745
| -21% | -$58.9K | 0.02% | 498 |
|
|
2015
Q2 | $300K | Hold |
22,914
| – | – | 0.02% | 433 |
|
|
2015
Q1 | $338K | Sell |
22,914
-4,220
| -16% | -$62.7K | 0.03% | 403 |
|
|
2014
Q4 | $374K | Buy |
27,134
+1,000
| +4% | +$13.4K | 0.03% | 384 |
|
|
2014
Q3 | $320K | Buy |
+26,134
| New | +$348K | 0.03% | 393 |
|
Other funds holding MPT
KCM Investment Advisors's MPT Position: Q2 2024 in Review
KCM Investment Advisors sold out of Medical Properties Trust (MPT) in Q2 2024, closing a stake of 10,533 shares — an estimated $49.5K sold.
KCM Investment Advisors first reported a position in MPT in Q3 2014 and held it in 39 quarters. The position peaked at $3.72M in Q4 2021. 500 funds tracked by Wall St. Rank hold MPT as of Q2 2024.
- KCM Investment Advisors reported no remaining Medical Properties Trust position as of Q2 2024 after selling out during the quarter.
- KCM Investment Advisors sold 10,533 Medical Properties Trust shares in Q2 2024, an estimated $49.5K.
- KCM Investment Advisors first reported a position in Medical Properties Trust in Q3 2014 and held it in 39 quarters.
- KCM Investment Advisors's Medical Properties Trust position peaked at $3.72M in Q4 2021.
- 500 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2024.
Based on KCM Investment Advisors's 13F filing for Q2 2024, filed 29 Jul 2024.